Maree Mastwyk

1.4k total citations · 1 hit paper
17 papers, 1.1k citations indexed

About

Maree Mastwyk is a scholar working on Psychiatry and Mental health, General Health Professions and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Maree Mastwyk has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 5 papers in General Health Professions and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Maree Mastwyk's work include Stress Responses and Cortisol (3 papers), Ethics in Clinical Research (3 papers) and Alzheimer's disease research and treatments (3 papers). Maree Mastwyk is often cited by papers focused on Stress Responses and Cortisol (3 papers), Ethics in Clinical Research (3 papers) and Alzheimer's disease research and treatments (3 papers). Maree Mastwyk collaborates with scholars based in Australia, United Kingdom and United States. Maree Mastwyk's co-authors include David Ames, Craig Ritchie, Colin L. Masters, Darryl Carrington, Konrad Beyreuther, Rudolph E. Tanzi, Andrew Mackinnon, Steve Macfarlane, Christine Mavros and Stephen N. Davis and has published in prestigious journals such as Biological Psychiatry, The British Journal of Psychiatry and Psychological Medicine.

In The Last Decade

Maree Mastwyk

15 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer Disease

2003 810 citations Craig Ritchie, Ashley I. Bush et al. Archives of Neurology profile →

Peers

Countries citing papers authored by Maree Mastwyk

Since Specialization

Citations

This map shows the geographic impact of Maree Mastwyk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maree Mastwyk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maree Mastwyk more than expected).

Fields of papers citing papers by Maree Mastwyk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maree Mastwyk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maree Mastwyk. The network helps show where Maree Mastwyk may publish in the future.

Co-authorship network of co-authors of Maree Mastwyk

This figure shows the co-authorship network connecting the top 25 collaborators of Maree Mastwyk. A scholar is included among the top collaborators of Maree Mastwyk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maree Mastwyk. Maree Mastwyk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Safety of Disclosing Amyloid Imaging Results to MCI and AD Patients 2023 ·Carl Taswell, (unknown), Maree Mastwyk, (unknown), (unknown), Joanne Robertson, David Darby, (unknown), Christopher C. Rowe	0
2	The anti‐amyloid treatment in asymptomatic Alzheimer’s disease (A4) study: Report of screening and recruitment characteristics of the Melbourne composite site 2020 ·Alzheimer s & Dementia ·(unknown), Maree Mastwyk, (unknown), Paul Yates, Oliver Langford, Rema Raman, Michael Donohue, Paul Aisen, Joanne Robertson, Christopher Fowler, (unknown), (unknown), Christopher C. Rowe, Reisa A. Sperling, Colin L. Masters	0
3	Safety of Disclosing Amyloid Imaging Results to MCI and AD Patients 2017 ·American Journal of Geriatric Psychiatry ·Carl Taswell, (unknown), Maree Mastwyk, (unknown), (unknown), David Darby, Victor L. Villemagne, Colin L. Masters, Christopher C. Rowe	14
4	Why attend a memory clinic? What do patients and their families want and/or expect? 2016 ·Australasian Journal on Ageing ·Maree Mastwyk, Briony Dow, Kathryn A. Ellis, David Ames	7
5	Disclosing a dementia diagnosis: what do patients and family consider important? 2014 ·International Psychogeriatrics ·Maree Mastwyk, David Ames, Kathryn A. Ellis, Edmond Chiu, Briony Dow	21
6	Health professionals' and students' perceptions of elder abuse 2013 ·Australasian Journal on Ageing ·Briony Dow, Courtney Hempton, (unknown), Kathryn A. Ellis, Susan Koch, Dina LoGiudice, Maree Mastwyk, Gill Livingston, Claudia Cooper, David Ames	12
7	Contrasting perceptions of health professionals and older people in Australia: what constitutes elder abuse? 2010 ·International Journal of Geriatric Psychiatry ·Courtney Hempton, Briony Dow, (unknown), Kathryn A. Ellis, Sebastian Koch, Dina LoGiudice, Maree Mastwyk, Gill Livingston, Claudia Cooper, David Ames	20
8	Predictors of adherence to atypical antipsychotics (risperidone or olanzapine) in older patients with schizophrenia: an open study of 3½ years duration 2009 ·International Journal of Geriatric Psychiatry ·Craig Ritchie, Susy Harrigan, Maree Mastwyk, Stephen Macfarlane, (unknown), David Ames	16
9	A comparison of the efficacy and safety of olanzapine and risperidone in the treatment of elderly patients with schizophrenia: an open study of six months duration 2006 ·International Journal of Geriatric Psychiatry ·Craig Ritchie, Ernest S. Chiu, Susy Harrigan, Stephen Macfarlane, Maree Mastwyk, Glenda M. Halliday, Harry Hustig, Kathryn Hall, (unknown), Daniel O’Connor, Jessica Opie, (unknown), John Snowdon, David Ames	20
10	Why participate in an Alzheimer’s disease clinical trial? Is it of benefit to carers and patients? 2003 ·Faculty of Health; Institute of Health and Biomedical Innovation ·Maree Mastwyk, Stephen Macfarlane, Dina LoGiudice, Karen A. Sullivan	1
11	The impact upon extra‐pyramidal side effects, clinical symptoms and quality of life of a switch from conventional to atypical antipsychotics (risperidone or olanzapine) in elderly patients with schizophrenia 2003 ·International Journal of Geriatric Psychiatry ·Craig Ritchie, (unknown), Susy Harrigan, Kathryn Hall, (unknown), Stephen Macfarlane, Maree Mastwyk, Daniel O’Connor, Jessica Opie, David Ames	63
12	Why Participate in an Alzheimer’s Disease Clinical Trial? Is It of Benefit to Carers and Patients? 2003 ·International Psychogeriatrics ·Maree Mastwyk, Stephen Macfarlane, Dina LoGiudice, Karen A. Sullivan	11
13	Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer Disease breakdown → 2003 ·Archives of Neurology ·Craig Ritchie, Ashley I. Bush, Andrew Mackinnon, Steve Macfarlane, Maree Mastwyk, Lachlan MacGregor, (unknown), Robert A. Cherny, Qiao‐Xin Li, (unknown), Darryl Carrington, Christine Mavros, Irene Volitakis, (unknown), David Ames, Stephen N. Davis, Konrad Beyreuther, Rudolph E. Tanzi, Colin L. Masters	810
14	Carer Impressions of Participation in Alzheimer’s Disease Clinical Trials: What Are Their Hopes? And Is It Worth It? 2002 ·International Psychogeriatrics ·Maree Mastwyk, Stephen Macfarlane, Craig Ritchie, Dina LoGiudice, Karen A. Sullivan	1
15	Enhanced adrenal sensitivity to adrenocorticotrophic hormone (ACTH) is evidence of HPA axis hyperactivity in Alzheimer's disease 1996 ·Psychological Medicine ·John T. O’Brien, David Ames, I. Schweitzer, Maree Mastwyk, Peter G. Colman	58
16	The Function of the Hypothalamic–Pituitary–Adrenal Axis in Alzheimer's Disease 1994 ·The British Journal of Psychiatry ·John T. O’Brien, Isaac Schweitzer, David Ames, Maree Mastwyk, Peter G. Colman	17
17	Cortisol suppression by dexamethasone in the healthy elderly: Effects of age, dexamethasone levels, and cognitive function 1994 ·Biological Psychiatry ·John T. O’Brien, Isaac Schweitzer, David Ames, Virginia Tuckwell, Maree Mastwyk	62

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact